Baldwin Investment Management, LLC
Source: SEC Form 13F · as of Mar 2026Baldwin Investment Management, LLC holds 18 biotech & pharma companies tracked by BioSniper, totaling $41.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$41.5M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 10,940 | $10.1M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 15,662 | $7.0M |
| ABBVAbbVie Inc. | 28,449 | $6.2M |
| JNJJOHNSON & JOHNSON | 17,653 | $4.3M |
| ABTABBOTT LABORATORIES | 39,819 | $4.1M |
| ZTSZoetis Inc. | 21,952 | $2.6M |
| CORCencora Inc. | 3,408 | $1.1M |
| PFEPFIZER INC | 36,398 | $1.0M |
| MCKMcKesson Corporation | 1,110 | $961K |
| NVONovo Nordisk A/S | 21,549 | $792K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,894 | $783K |
| MRKMerck & Co., Inc. | 5,370 | $646K |
| IMNMImmunome Inc. | 25,394 | $570K |
| BMYBRISTOL MYERS SQUIBB CO | 8,400 | $509K |
| IQVIQVIA Holdings Inc. | 2,758 | $470K |
| INCYIncyte Corp. | 2,480 | $233K |
| AMGNAMGEN INC | 579 | $204K |
| OCGNOcugen, Inc. | 25,000 | $45K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.